Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs ; day:17 ; month:12 ; year:2022 ; pages:1-17
Rheumatology and therapy ; (17.12.2022), 1-17
- Creator
-
Winthrop, Kevin L.
Yndestad, Arne
Henrohn, Dan
Danese, Silvio
Marsal, Sara
Galindo, Maria
Woolcott, John C.
Jo, Hyejin
Kwok, Kenneth
Shapiro, Andrea B.
Jones, Thomas V.
Diehl, Annette
Su, Chinyu
Panes, Julian
Cohen, Stanley B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-022-00507-z
- URN
-
urn:nbn:de:101:1-2023022821023544429116
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Winthrop, Kevin L.
- Yndestad, Arne
- Henrohn, Dan
- Danese, Silvio
- Marsal, Sara
- Galindo, Maria
- Woolcott, John C.
- Jo, Hyejin
- Kwok, Kenneth
- Shapiro, Andrea B.
- Jones, Thomas V.
- Diehl, Annette
- Su, Chinyu
- Panes, Julian
- Cohen, Stanley B.
- SpringerLink (Online service)
Other Objects (12)
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Rheumatoide Arthritis: Kardiovaskuläre Komplikationen unter Tofacitinib
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Treatment recommendations for psoriatic arthritis
Macrophage dysfunction in Psoriatic Arthritis
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Rheumatoide Arthritis: Kardiovaskuläre Komplikationen unter Tofacitinib
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Treatment recommendations for psoriatic arthritis
Macrophage dysfunction in Psoriatic Arthritis
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Rheumatoide Arthritis: Kardiovaskuläre Komplikationen unter Tofacitinib
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Treatment recommendations for psoriatic arthritis